Share your perspective and help improve the health of our community! We are conducting a Community Health Needs Assessment (CHNA) to help us better understand the health needs of the community our health system serves. Learn more and take the short survey.
We are unfortunately once again facing a critical shortage of IV/IM lorazepam (2mL vials) and down to a limited supply (~2 weeks). We will be implementing an EPIC alert but wanted to also notify you directly due to the far reaching nature of this shortage.
For clinical scenarios that require IV/IM lorazepam critically (e.g. status epilepticus): please proceed with order. Otherwise, some options for managing this shortage include:
NOTE: There are no direct dosage conversions between the benzodiazepines because each has a distinct pharmacokinetic profile that dictates the agent's therapeutic use and dosing. Below are conservative recommendations and information regarding the onset and duration.
|
Agent |
Onset of Action (min) – Intravenous |
Duration of Action (hours) – Intravenous |
Onset of Action (min) – Intramuscular |
Duration of Action (hours) - Intramuscular |
Half Life (hours) |
Conservative estimate on equivalent dose1 |
|
Lorazepam |
5 to 20 |
6 to 8 |
15 to 30 |
6 to 8 |
8 to 15 |
1mg |
|
Diazepam |
1 to 5 |
0.3 to 0.5 |
Erratic/slow |
Erratic/slow |
20 to 120 |
5mg |
|
Midazolam |
1 to 5 |
< 2 |
5 to 15 |
< 2 |
3 to 11 |
2mg |